Inventor · disambiguated record
Stuart Daniel Barnscher
Also filed as: BARNSCHER STUART · BARNSCHER STUART D · BARNSCHER STUART DANIEL
10 granted patents·11 pending applications·23 citations·filing 2012–2025
85Inventor score
Top patents by PatentIndex Score
21 records- 0192US9879086B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2015·Granted Jan 30, 2018·11 cites·90 claims
- 0287US11000598B2Anti-HER2 biparatopic antibody-drug conjugates and methods of useZYMEWORKS INC·Filed 2019·Granted May 11, 2021·5 cites·17 claims
- 0380US12152083B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2023·Granted Nov 26, 2024·0 cites·27 claims
- 0480US10414822B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2018·Granted Sep 17, 2019·2 cites·34 claims
- 0579US10450378B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2015·Granted Oct 22, 2019·2 cites·61 claims
- 0676US11208497B2Antibodies comprising C-terminal light chain polypeptide extensions and conjugates and methods of use thereofZYMEWORKS INC·Filed 2014·Granted Dec 28, 2021·2 cites·39 claims
- 0773US11312748B2Derivatives of dolaproine-dolaisoleucine peptidesAGENSYS INC·Filed 2019·Granted Apr 26, 2022·1 cites·16 claims
- 0866US12433952B2Antibody-drug conjugates targeting folate receptor alpha and methods of useZYMEWORKS BC INC·Filed 2024·Granted Oct 7, 2025·0 cites·30 claims
- 0965US12357701B2Anti-HER2 biparatopic antibody-drug conjugates and methods of useZYMEWORKS BC INC·Filed 2021·Granted Jul 15, 2025·0 cites·33 claims
- 1064US2022204557A1Derivatives of dolaproine-dolaisoleuine peptidesAGENSYS INC·Filed 2022·Application pending·0 cites
- 1162US11591405B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2019·Granted Feb 28, 2023·0 cites·18 claims
- 1261US2021260210A1Anti-her2 biparatopic antibody-drug conjugates and methods of useZYMEWORKS INC·Filed 2019·Application pending·0 cites
- 1360US2025339552A1Antibody-drug conjugates targeting folate receptor alpha and methods of useZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 1452US2024269309A1Camptothecin analogues, conjugates and methods of useZYMEWORKS INC·Filed 2022·Application pending·0 cites
- 1549US2025222128A1Antibody drug-conjugates targeting c-met and methods of use thereofZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 1643US2025235548A1Antibody-drug conjugates targeting napi2b and methods of useZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 1743US2025295799A1Antibody-drug conjugates targeting glypican-3 and methods of useZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 1843US2017190735A1Derivatives of dolaproine-dolaisoleuine peptidesAGENSYS INC·Filed 2015·Application pending·0 cites
- 1942US2025277030A1Anti-napi2b antibodies and methods of useZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 2042US2025170266A1Immunomodulator purine-derived compounds, conjugates thereof, and methods of use thereofZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 2137US2013190248A1Substituted peptide analogsMENDELSOHN BRIAN ALAN·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →